About US
Contact us
-
American Regent Initiates Nationwide Voluntary Recall of Sodium Bicarbonate Injection, USP 7.5% and 8.4%, 50 mL Single Dose Vials Due to Particulate MatterSHIRLEY, N.Y., Dec. 23, 2010 /PRNewswire/ -- American Regent is conducting a nationwide voluntary recall to the consumer and user level of ALL unexpired lots of the following products: S o di u m B i2010/12/29
-
FDA Halts J&J Study Of Pain Drug Over SafetyWASHINGTON -- Johnson & Johnson said Tuesday that a study of its experimental pain drug, fulranumab, has been halted after the Food and Drug Administration put the trial on hold over concerns that2010/12/29
-
Teva Settles Takeda Patent LitigationIsrael-based pharmaceutical major Teva Pharmaceutical has reached a settlement with Takeda Pharmaceutical. Teva has entered into an agreement with Takeda over claims that the company breached pate2010/12/28
-
Sanofi-Aventis Acquires Ascendis Drug Delivery TechnologySanofi-Aventis has acquired Ascendis' proprietary TransCon Linker and Hydrogel carrier technology, allowing drug compounds to be released into the body in a precise, time-controlled fashion. The t2010/12/28
-
Amylin And Lilly Seek Expanded Byetta ApprovalNEW YORK -- Eli Lilly and Co. and Amylin Pharmaceuticals Inc. said Wednesday they are asking the Food and Drug Administration to expand approval for their type 2 diabetes drug Byetta. The drug make2010/12/27
-
Pfizer Recalling More Lipitor BottlesDrug maker Pfizer says it is recalling another 19,000 bottles of its Lipitor cholesterol medication following reports of musty odors from the bottles. The company has already pulled 370,000 Lipitor2010/12/27
-
Merck announces FDA approval for GARDASIL against HPV-related anal cancerMerck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 12010/12/24
-
Pfizer seeks FDA and EMA approval for expanded use of Prevnar 13 for pneumococcal diseasePfizer Inc (NYSE: PFE) today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand th2010/12/24
-
Abbott and AstraZeneca End License Agreement for the Development of CertriadABBOTT PARK, Ill., Dec. 22, 2010 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) announced today that Abbott and AstraZeneca will discontinue their joint collaboration for the development of CERTRIAD󍤚/12/23
-
American Regent initiates nationwide voluntary recall of certain lots of Dexamethasone Sodium Phosphate InjectionAmerican Regent is conducting a nationwide voluntary recall. This voluntary recall was initiated because some vials of certain lots either contain particulates or have the potential to form particu2010/12/23